BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ChamberMaster//Event Calendar 2.0//EN
METHOD:PUBLISH
X-PUBLISHED-TTL:P3D
REFRESH-INTERVAL:P3D
CALSCALE:GREGORIAN
BEGIN:VEVENT
DTSTART:20230424T020000Z
DTEND:20230424T030000Z
X-MICROSOFT-CDO-ALLDAYEVENT:FALSE
SUMMARY:Healthcare Council: April 2023 Video Conference
DESCRIPTION:The Healthcare Council gathers industry stakeholders\, including hospitals\, pharmaceuticals\, medical devices\, insurers and other interested companies to discuss current issues affecting the industry\, find solutions\, and collaborate on advocacy and programming initiatives.\n\n\n\nThe next Healthcare Council meeting will convene virtually on April 24. Agenda for Healthcare Council (April 2023) is as follows:\n\n\n	Update/Progress on Healthcare Whitepaper \n	A general overview of the pharmaceutical regulation changes and how PReMA engages with ThFDA for the new and incoming regulations by Em-oat Lertpiya\, Head of Regulatory Affairs for Thailand and LCM of Janssen-Cilag \n	Thai Innovation List Background by Amara (Nacky) Chunplang\, Corporate Affairs Lead\, Thailand and Indochina of Pfizer\n	Update on government engagement by AMCHAM Government Affairs team\n	Other matters \n\nPlease note that all AMCHAM members are welcome to join Council Meetings. If you would like more information on the activities of the Healthcare Council\, please contact bonus@amchamthailand.com.
X-ALT-DESC;FMTTYPE=text/html:<p>The Healthcare Council gathers industry stakeholders\, including hospitals\, pharmaceuticals\, medical devices\, insurers and other interested companies to discuss current issues affecting the industry\, find solutions\, and collaborate on advocacy and programming initiatives.<br />\n<br />\nThe next Healthcare Council meeting will convene virtually on April 24. <strong><span style="font-family:open sans\,sans-serif\;">Agenda for Healthcare Council (April 2023) is as follows:</span></strong></p>\n\n<ul>\n	<li style="margin-bottom:0in\;margin-left:0in\;"><span style="font-family:open sans\,sans-serif\;">Update/Progress on Healthcare Whitepaper </span></li>\n	<li style="margin-left:0in\;"><span style="font-family:open sans\,sans-serif\;">A general overview of the pharmaceutical regulation changes and how PReMA engages with ThFDA for the new and incoming regulations by</span> <a href="https://www.linkedin.com/in/em-oat-lertpiya-0b29ab11b/">Em-oat Lertpiya</a><span style="font-family:open sans\,sans-serif\;">\, Head of Regulatory Affairs for Thailand and LCM of Janssen-Cilag </span></li>\n	<li style="margin-left:0in\;"><span style="font-family:open sans\,sans-serif\;">Thai Innovation List Background by </span><a href="https://www.linkedin.com/in/nacky/">Amara (Nacky) Chunplan<span style="color: rgba(0\, 0\, 0\, 0.9)\; font-family: -apple-system\, system-ui\, BlinkMacSystemFont\, &quot\;Segoe UI&quot\;\, Roboto\, &quot\;Helvetica Neue&quot\;\, &quot\;Fira Sans&quot\;\, Ubuntu\, Oxygen\, &quot\;Oxygen Sans&quot\;\, Cantarell\, &quot\;Droid Sans&quot\;\, &quot\;Apple Color Emoji&quot\;\, &quot\;Segoe UI Emoji&quot\;\, &quot\;Segoe UI Emoji&quot\;\, &quot\;Segoe UI Symbol&quot\;\, &quot\;Lucida Grande&quot\;\, Helvetica\, Arial\, sans-serif\;">g</span><span style="font-family:open sans\,sans-serif\;">\, </span></a>Corporate Affairs Lead\, Thailand and Indochina of&nbsp\;Pfizer</li>\n	<li style="margin-left:0in\;"><span style="font-family:open sans\,sans-serif\;">Update on government engagement by AMCHAM Government Affairs team</span></li>\n	<li style="margin-bottom:12.0pt\;margin-left:0in\;"><span style="font-family:open sans\,sans-serif\;">Other matters&nbsp\;</span></li>\n</ul>\nPlease note that all AMCHAM members are welcome to join Council Meetings. If you would like more information on the activities of the Healthcare Council\, please contact bonus@amchamthailand.com.&nbsp\; &nbsp\;
LOCATION:Online videoconference
UID:e.3314.2492
SEQUENCE:3
DTSTAMP:20260420T034223Z
URL:http://www.connect.amchamthailand.com/events/details/healthcare-council-april-2023-video-conference-2492
END:VEVENT

END:VCALENDAR
